Free Review Articles on Gastrointestinal stromal cell tumor GIST                                 Metatextbook

Freie Reviews über Gastrointestinaler Stromazelltumor                                 Look here for Journal Homepages




  • Gastrointestinal stromal cell tumor GIST
  • Kidney (Neoplasm)
  • Sunitinib
  • Menetrier s disease
  • Arthritis (rheumatoid)
  • Bartonella henselae
  • Candida (BASKET)
  • Coccidioidomycosis
  • Ovary (Neoplasia)
  • Histoplasmosis
  • Testis (Neoplasia)
  • Lymphoma (Hodgkin)
  • Calcium (Hypercalciemia)
  • Cryptococcosis
  • Langerhans cell histiocytosis
  • Liver (Diseases)
  • Lepra
  • Lung (Neoplasm)
  • Lymphoma (BASKET)
  • Crohn s disease
  • Mycobacterium avium
  • Osteoarthritis
  • Sarcoidosis
  • Tuberculosis
  • Wegener s granulomatosis
  • Pneumocystis carinii Pneumocystis jirovicii
  • Paracoccoidomycosis
  • Bacillus calmette guerin
  • Pseudolymphoma (Lymphomatoid granulomatosis)
  • Lipoid pneumonia
  • Lung (Toxicology)
  • Polymyositis
  • Silicone
  • Slack skin disease
  • Fat necrosis subcutaneous of the newborn
  • Pseudolymphoma (Plasma cell granuloma)
  • Testis (Neoplasia Seminoma)
  • Carney s complex
  • Nervous system (Neoplasia Paraganglioma)
  • Neoplasia (Inherited)
  • Imatinib
  • Changes in terminology
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    11969Sarcoma of the stomach: a review of 39 cases.



    +-nlSouth Med J 62(9):1064-71 (1969)
    22008Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate.



    +-nlTher Clin Risk Manag 4(1):149-62 (2008)
    32007Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST).



    +-nlTher Clin Risk Manag 3(2):341-8 (2007)
    42005Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.



    +-nlHealth Technol Assess 9(25):1-142 (2005)
    52006Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.



    +-nlCan J Gastroenterol 20(3):157-63 (2006)
    62009Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.



    +-nlCan J Surg 52(1):31-8 (2009)
    71998Gastrointestinal stromal tumours: an update.



    +-nlSarcoma 2(3-4):133-41 (1998)
    82006Clinical presentation and treatment of gastrointestinal stromal tumors.



    +-nlTumori 92(4):279-84 (2006)
    92008Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    +-nlAnn Oncol 19 Suppl 2(-):ii35-8 (2008)
    102007Advances in the treatment of gastrointestinal stromal tumours.



    +-nlAnn Oncol 18 Suppl 10(-):x20-4 (2007)
    112007Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features.



    +-nlAnn Oncol 18 Suppl 6(-):vi136-40 (2007)
    122006Gastrointestinal stromal tumor (GIST).



    +-nlAnn Oncol 17 Suppl 10(-):x280-6 (2006)
    132005Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.



    +-nlAnn Oncol 16(4):566-78 (2005)
    142008Genetic aberrations of gastrointestinal stromal tumors.



    +-nlCancer 113(7):1532-43 (2008)
    152005Gastrointestinal stromal tumor: 5 years later.



    +-nlCancer 104(9):1781-8 (2005)
    162005Update on the biology and therapy of gastrointestinal stromal tumors.



    +-nlCancer Control 12(1):44-56 (2005)
    172001Gastrointestinal stromal tumors.



    +-nlCancer Control 8(3):252-61 (2001)
    182007Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.



    +-nlClin Cancer Res 13(5):1367-73 (2007)
    192004Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).



    +-nlCancer Biol Ther 3(3):251-8 (2004)
    202003Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.



    +-nlPathol Oncol Res 9(1):13-9 (2003)
    212009Gastrointestinal stromal tumors: a 19 year experience.



    +-nlIsr Med Assoc J 11(2):98-102 (2009)
    222007Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.



    +-nlJ Clin Invest 117(1):70-80 (2007)
    232006An update on molecular genetics of gastrointestinal stromal tumours.



    +-nlJ Clin Pathol 59(6):557-63 (2006)
    242009Current standards and progress in understanding and treatment of GIST.



    +-nlSwiss Med Wkly 139(7-8):90-102 (2009)
    252004Management of gastrointestinal stromal tumors: from diagnosis to treatment.



    +-nlSwiss Med Wkly 134(11-12):145-53 (2004)
    262006Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib.



    +-nlRadiographics 26(2):481-95 (2006)
    272003Gastrointestinal stromal tumors: radiologic features with pathologic correlation.



    +-nlRadiographics 23(2):283-304, 456; quiz 532 (2003)
    282010Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.



    +-nlAnn Oncol 21 Suppl 5(-):v98-102 (2010)
    292010Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.



    +-nlAnn Oncol 21(2):208-15 (2010)
    302009Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    +-nlAnn Oncol 20 Suppl 4(-):64-7 (2009)
    312010Molecular basis and management of gastrointestinal stromal tumors.



    +-nlWorld J Gastroenterol 16(22):2726-34 (2010)
    322010Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.



    +-nlJ Clin Endocrinol Metab 95(7):3111-7 (2010)
    332009Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors.



    +-nlJ Clin Endocrinol Metab 94(10):3656-62 (2009)
    342010Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors.



    +-nlOncologist 15(3):300-7 (2010)
    352010Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.



    +-nlCancer 116(22):5126-37 (2010)
    362010The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.



    +-nlCancer 116(8):1847-58 (2010)
    372007A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST.



    +-nlIsr Med Assoc J 9(11):810-2 (2007)
    382011Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.



    +-nlHealth Technol Assess 15(25):1-178 (2011)
    392010Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours.



    +-nlHealth Technol Assess 14(Suppl. 2):63-70 (2010)
    402006Gastrointestinal stromal tumors (GIST).



    +-nlGastroenterol Clin Biol 30 Spec No 2(-):2S98-2S101 (2006)
    412005The radiology of gastrointestinal stromal tumours (GIST).



    +-nlCancer Imaging 5(-):150-6 (2005)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.